Jazz Pharmaceuticals

Yahoo Finance • 2 days ago

Stock Market Today: Nasdaq, Dow Hold Gains Before Nvidia Earnings; Vertiv, Keysight Advance (Live Coverage)

Stock Market Today: The Dow Jones index rises Wednesday ahead of Nvidia earnings. First Solar stock sinks on downbeat revenue guidance. Continue Reading... Full story

Yahoo Finance • 2 days ago

Stock Market Today: Dow Advance Melts Before Nvidia Earnings; Missile Firm L3Harris Eyes Entry (Live Coverage)

Stock Market Today: The Dow Jones index rises Wednesday ahead of Nvidia earnings. First Solar stock sinks on downbeat revenue guidance. Continue Reading... Full story

Yahoo Finance • 2 days ago

Stock Market Today: Dow Up 100 Points Before Nvidia Earnings; This Drug Firm Breaks Out (Live Coverage)

Stock Market Today: The Dow Jones index rises Wednesday ahead of Nvidia earnings. First Solar stock sinks on downbeat revenue guidance. Continue Reading... Full story

Yahoo Finance • 24 days ago

Truist Securities Raises Jazz Pharmaceuticals (JAZZ) Price Target After HERIZON-GEA Trial

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) ranks among the mid-cap stocks to buy according to top investors. Truist Securities increased its price target for Jazz Pharmaceuticals plc (NASDAQ:JAZZ) to $230 from $220 on January 12, preserving a... Full story

Yahoo Finance • 2 months ago

Jazz Pharmaceuticals to Participate in Upcoming Investor Events

DUBLIN, Dec. 17, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the following investor events: Zanidatamab HERIZON-GEA-01 Investor Webcast on Friday, January 9, 2026 The... Full story

Yahoo Finance • 2 months ago

Iambic Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

SAN DIEGO, December 16, 2025--(BUSINESS WIRE)--Iambic, a clinical-stage life sciences and technology company advancing novel medicines through its AI-driven discovery and development platform, today announced that Tom Miller, Ph.D. (Co-Fou... Full story

Yahoo Finance • 3 months ago

This Biotech Fund Just Made a $22 Million Bet on Pharvaris Stock — Is It a Buy?

Key Points Austin-based Saturn V Capital Management acquired 886,332 shares of Pharvaris in the third quarter. Saturn V now holds 886,332 PHVS shares valued at $22.1 million. PHVS is a new addition, accounting for 4.9% of 13F AUM, which p... Full story

Yahoo Finance • 3 months ago

Hedge Fund Boosts Stake in Amylyx Stock to $63 Million — Should Investors Follow?

Key Points Austin-based Saturn V Capital Management added 1.3 million shares of Amylyx Pharmaceuticals in the third quarter. The overall position increased in value by $41.2 million from quarter to quarter. Saturn V now holds 4.6 million... Full story

Yahoo Finance • 3 months ago

Why a Biotech Fund Made Dyne Therapeutics One of Its Biggest Stock Bets

Key Points Austin-based Saturn V Capital Management added 1.2 million shares of Dyne Therapeutics during the third quarter. The overall position increased in value by $20 million from quarter to quarter. Saturn V now holds nearly 2.7 mill... Full story

Yahoo Finance • 3 months ago

Top pharmaceutical stocks by Quant to focus on as Novo Nordisk slides

[Close-up of a male hand holding a pill bottle pouring medication into his hand] Trevor Williams The recent news [https://seekingalpha.com/news/4525254-novo-nordisk-slides-as-ozempic-pill-fails-to-slow-alzheimers-disease-progression-in-la... Full story

Yahoo Finance • 3 months ago

Booking, Carvana upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Wedbush upgraded Carvana (CVNA) to Out... Full story

Yahoo Finance • 3 months ago

Here are Monday’s Top Wall Street Analyst Research Calls: Baidu, Carvana, Exact Sciences, Ferrari, Marvell Technology, Meta Platforms and More

mezzotint / Shutterstock.com Quick Read With limited economic data, the Thanksgiving holiday on Thursday, and an early close on Friday, many on Wall Street expect a quieter week than the preceding one. There appears to be a tug-of-war no... Full story

Yahoo Finance • 3 months ago

Zymeworks shifts to a royalty-driven business model

[Golden Percentage Symbol] fatido Zymeworks (ZYME [https://seekingalpha.com/symbol/ZYME]) on Tuesday announced plans to focus on a royalty-driven growth model backed by its internal R&D engine and licensing arrangements with companies suc... Full story

Yahoo Finance • 3 months ago

Stock market today: Dow, S&P 500, Nasdaq slide as sell-off resumes ahead of Nvidia earnings, jobs data

US stocks saw a third day of losses on Monday amid doubts about interest rate cuts, as investors looked ahead to high-stakes Nvidia (NVDA) earnings and the delayed September jobs report. The tech-heavy Nasdaq Composite (^IXIC) erased mode... Full story

Yahoo Finance • 3 months ago

Stocks making the biggest moves midday: Brinker International, Alphabet, Quantum Computing & more

Check out the companies making the biggest moves midday: Brinker International — The Chili's parent jumped more than 8%, on pace for its largest one-day advance since April. Short interest amounts to 12% of Brinker's float, FactSet data sh... Full story

Yahoo Finance • 3 months ago

Stock Market Today: S&P 500, Nasdaq Recover After Weak Start to Week

This live blog is refreshed periodically throughout the day with the latest updates from the market.To find the latest Stock Market Today threads, click here. Happy Monday. This is TheStreet’s Stock Market Today for Nov. 17, 2025. You can... Full story

Yahoo Finance • 3 months ago

Biggest stock movers Monday: GOOG, DELL, QUBT, XPEV, and more

[A blue financial chart with arrows pointing up] Olena_T Stock futures inched lower on Monday, signaling a cautious start to the week. Investors are anticipating a renewed stream of official U.S. economic data releases, delayed by the rec... Full story

Yahoo Finance • 3 months ago

Stocks making the biggest moves premarket: Alphabet, Zymeworks, lithium producers, Quantum Computing, Clearwater Analytics and more

Check out the companies making headlines in premarket trading. Alphabet — The YouTube and Google owner rose more than 4% after Warren Buffett's Berkshire Hathaway revealed it took a more than $4 billion stake in Alphabet in the third quart... Full story

Yahoo Finance • 3 months ago

Jazz, Zymeworks’ Ziihera trial shows significant PFS improvement, shares rally

[Biomedical Researchers Conduct Experiments in a Modern Laboratory. Female Scientist Preparing a Set of Samples in Test Tubes with Purple Caps. Colleague Analyzes Data on a Computer in the Background] gorodenkoff/iStock via Getty Images... Full story

Yahoo Finance • 4 months ago

Jazz Pharmaceuticals Appoints Ted W. Love, M.D., to its Board of Directors

Dr. Love, a biopharmaceutical industry veteran, brings extensive executive leadership and board experience with proven success in creating shareholder value DUBLIN, Oct. 28, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) tod... Full story